Morningstar Research

CRISPR Therapeutics AG (CRSP) Stock Undervalued; Morningstar Recommends BUY Call with $106 Fair Value

CRISPR Therapeutics AG (CRSP) Stock Undervalued; Morningstar Recommends BUY Call with $106 Fair Value

Morningstar has issued a BUY recommendation on CRISPR Therapeutics AG (NASDAQ: CRSP), underscoring the stock’s significant undervaluation and robust long-term prospects, in its latest research repo

Fedex Stock Fair Value at $237: Morningstar Research Maintains HOLD Ratings

Fedex Stock Fair Value at $237: Morningstar Research Maintains HOLD Ratings

In its latest equity analyst report, Morningstar maintains a “Hold” (fairly valued) recommendation on FedEx Corp (NYSE: FDX), reflecting a nuanced view of the company’s current valuation, operation

Tripadvisor Stock Price Target at $18.5: Morningstar Research

Tripadvisor Stock Price Target at $18.5: Morningstar Research

In its latest analyst report, Morningstar maintains a "Buy" recommendation on Tripadvisor Incorporated (TRIP), highlighting the company’s undervalued status, strategic opportunities, and persistent

Shopify Stock Price Target at $120: Morningstar Research

Shopify Stock Price Target at $120: Morningstar Research

Shopify continues to validate its position as a dominant player in the e-commerce infrastructure space, with Morningstar reiterating a Buy rating and a fair value estimate of $120 per share, repres

Sanofi Stock Price Target at $55: Morningstar Research

Sanofi Stock Price Target at $55: Morningstar Research

Sanofi, the French pharmaceutical heavyweight, has earned a reaffirmed BUY rating from Morningstar as of May 2025.

Cloudflare Stock Fair Value Raised to $130 by Morningstar Research

Cloudflare Stock Fair Value Raised to $130 by Morningstar Research

Cloudflare, the mid-cap technology firm synonymous with distributed network security and web performance, received an upgraded fair value estimate of $130 per share from Morningstar, reflecting gro

Pages